Skip to main content

Unable to load price data. Sorry.


Matrixx Initiatives, Inc. (NASDAQ:MTXX)

CAPS Rating: No stars

The Company develops, produces, markets and sells innovative, over-the-counter healthcare products.

Unable to load market data for this Ticker. Sorry.



How do you think NASDAQ:MTXX will perform against the market?

Add Stock to CAPS Watchlist

All Players

119 Outperform
5 Underperform

All-Star Players

16 Outperform
1 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:MTXX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Madmykl (94.42)
Submitted December 02, 2007

Their Zicam product has good potential. As a physician I can read their research a little more deeply and the research appears okay... that is, there IS an effect with the product and the effect is substantial. Even though they talk about it being a… More

Jaspers0Debt (57.13)
Submitted June 16, 2009

Thumbs downing this to try and get some of my points back. Stock fell 50% today befor being closed for trading because of an FDA report saying that their sole product Ziacam is causing harm to patients. Apparently it is not only an effective cold… More


Fools bullish on NASDAQ:MTXX are also bullish on:

Fools bearish on NASDAQ:MTXX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MTXX.


Member Avatar Deandra88 (< 20) Submitted: 4/29/2008 4:27:32 PM : Outperform Start Price: $13.64 NASDAQ:MTXX Score: -207.80

With the double failure to produce enough flu vaccine and produce the right strain of vaccine in the last two years it is inevitable that consumer confidence will focus on drugs with a concentration on the over-the-counter homeopathic, variety.

Their products are flying off the shelf in Duane Reade in NY, and I'm doing hands on research of their product placements in this popular drug store chain and other chains, and I'm happy to see their placement is prime eye-level shelving, with orientation toward the front of the store.

On a personal level, I am greatly impressed with the results of preventing a minor cold from changing into a major one.

My overall rational is that with their commercials and homeopathy being on the rise due to many conventional healthcare failures, an affordable share price and positive consumer reviews, this is a company that could prove attractive to a buy-out by a larger pharmaceutical company looking to grab some market share. I consider this a good value stock, and I've bought shares at $13.46.


Member Avatar GCBECKWITH (< 20) Submitted: 3/24/2008 1:26:53 PM : Outperform Start Price: $15.60 NASDAQ:MTXX Score: -223.78

Matrixx Initiatives, Inc. makers of Zicam, specializes in over-the-counter medications and cold remedies. With the healthcare costs continuing to rise, I believe the over-the-counter markets are going to boom, epecially if the pessimistic outlook of companies offering less healthcare benefits turn out to be true. I already know people who opt to try over-the-counter medications instead of going to the Doctor because their co-pay is more than they can afford.


Member Avatar caseykimma (42.57) Submitted: 3/22/2008 7:25:52 PM : Outperform Start Price: $15.04 NASDAQ:MTXX Score: -226.44

another "Hot 5-Star Stock" that looks like it has some good growth in its future.


Find the members with the highest scoring picks in MTXX.

Score Leader


BrucePro (46.03) Score: +230.17

The Score Leader is the player with the highest score across all their picks in MTXX.

Member Name Member
Call Time
Score Commentary
BrucePro 46.03 3/28/2008 Underperform 5Y $15.00 -41.70% +188.47% +230.17 0 Comment
miami33154 50.78 1/29/2007 Underperform NS $16.22 -46.09% +173.09% +219.18 0 Comment
2acrerock 59.91 1/8/2007 Underperform 3W $15.18 -42.39% +175.79% +218.18 0 Comment
wcwhiner 28.89 12/14/2010 Underperform NS $7.98 +9.59% +192.79% +183.20 0 Comment
SanDieguito 92.51 6/14/2010 Underperform 5Y $4.62 +89.29% +231.02% +141.73 0 Comment
latestartr < 20 6/14/2010 Outperform 5Y $4.70 +86.06% +230.75% -144.68 0 Comment
BarryLyndon < 20 6/14/2010 Outperform 5Y $4.89 +78.83% +229.56% -150.72 0 Comment
Dobbes < 20 6/14/2010 Outperform 5Y $4.89 +78.83% +230.06% -151.23 0 Comment
Sandy1260 < 20 6/15/2010 Outperform 5Y $4.91 +78.11% +231.74% -153.63 0 Comment
Anthem27 72.97 8/23/2010 Outperform 5Y $5.22 +67.53% +238.62% -171.09 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MTXX.